Ultra Market Research | Global Cardiology Devices Market
Global Cardiology Devices Market
Report ID : 930
Category : Medical-Devices
No Of Pages : 95
Published on: January 2025
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Global Cardiology Devices Market
Introduction
The global cardiology devices market involves a wide scope of medical devices intended to diagnose, treat, and manage cardiovascular diseases. Cardiovascular diseases are among the leading causes of death globally; thereby, cardiology devices form an integral part of healthcare. The devices range from diagnostic tools such as electrocardiograms (ECGs), imaging systems, and therapeutic equipment such as pacemakers, defibrillators, and stents, among others. The market has also been transformed with recent advancements in minimally invasive technologies and artificial intelligence. The global cardiology devices market, according to recent estimates, was valued at USD 50 billion in 2024 and is expected to grow at a CAGR of 7.5% from 2025 to 2030, driven by increasing prevalence of cardiovascular conditions and technological innovations.
Segmentation
Diagnostic Devices
Electrocardiographs (ECG)
12-Lead ECG
Single-Lead ECG
Others
Imaging Systems
Echocardiography
Cardiac MRI
Others
Holter Monitors
Analog Holter Monitors
Digital Holter Monitors
Others
Others
Therapeutic Devices
Cardiac Rhythm Management Devices
Pacemakers
Single Chamber Pacemakers
Dual Chamber Pacemakers
Defibrillators
Implantable Cardioverter Defibrillators (ICDs)
External Defibrillators
Stents
Drug-Eluting Stents
Bare Metal Stents
Others
Heart Pumps
Ventricular Assist Devices
Intra-Aortic Balloon Pumps
Others
Monitoring Devices
Wearable Devices
Smartwatches with ECG Functionality
Chest Straps
Others
Remote Patient Monitoring Systems
Mobile-Based Monitoring Devices
Stationary Monitoring Systems
Others
Surgical Devices
Catheters
Angiographic Catheters
Electrophysiology Catheters
Valves
Transcatheter Heart Valves
Surgical Heart Valves
Others
List of Market Players
Medtronic (USA)
Abbott Laboratories (USA)
Boston Scientific Corporation (USA)
GE Healthcare (USA)
Siemens Healthineers (Germany)
Philips Healthcare (Netherlands)
Edwards Lifesciences (USA)
Terumo Corporation (Japan)
Biotronik (Germany)
LivaNova PLC (UK)
Nihon Kohden Corporation (Japan)
Zoll Medical Corporation (USA)
MicroPort Scientific Corporation (China)
Getinge AB (Sweden)
Shree Pacetronix Ltd. (India)
Drivers
The increasing prevalence of cardiovascular diseases in the global world, responsible for around 17.9 million deaths each year, is one of the key driving factors of this market. Lifestyle and diet patterns with increasing age groups and lack of physical activities further increased the situation. Cardiovascular care, such as AI-assisted diagnostics, has become highly accurate and efficient due to technical innovations. In addition, adoption of minimally invasive procedures that have decreased patient recovery times accelerates market growth. Government initiatives along with investments into healthcare in the emerging economies of the world, contribute significantly to expansion of the market.
Restraints
Despite the huge growth potential, the global cardiology devices market has several hurdles. High costs of advanced cardiology devices and their procedures may not be accessible in low-income and middle-income countries. Stringent regulatory requirements and prolonged processes associated with product approvals generally prolong the launch times of the products. Further, inadequacy in skilled professional availability in certain regions hinders the effective utilization of advanced devices. Issues related to reimbursement and a lack of awareness about cardiovascular diseases in underdeveloped areas also limit market growth.
Opportunities
There is a great scope in the global cardiology devices market, particularly in emerging economies that are improving health care infrastructure at a fast pace. Growing awareness about cardiovascular health and increasing government spending on healthcare are factors conducive to expansion of this market. With the advancement in technology, integrating AI and IoT in medical devices provides innovative solutions for diagnosis and treatment. The upsurge of demand for telemedicine and remote patient monitoring systems creates new windows of opportunity for market players to come up with advanced, user-friendly devices that meet the evolving needs of consumers.
Trend
The cardiology devices market is increasingly witnessing wearable technology adoption due to consumer demand for real-time health monitoring. Smartwatches and fitness trackers are now able to monitor ECGs for cardiac health monitoring. AI analytics in diagnostic tools have become standard, which improve predictive capabilities and the ability to detect diseases at an early stage. Bioresorbable stents and 3D-printed heart valves represent the future of therapeutic devices. Telemedicine is also integrated into cardiology devices, which are now used to consult patients remotely and with better outcomes.
Approved Products Pipeline
Medtronic’s Micra AV (Reg)
Abbott’s Amplatzer Amulet (Reg)
Boston Scientific’s WATCHMAN FLX (Pre-Reg)
Edwards Lifesciences’ Sapien 3 Ultra (Reg)
Biotronik’s BIOMONITOR III (Reg)
GE Healthcare’s Revolution Apex CT Scanner (Pre-Reg)
Philips’ Azurion System (Reg)
Terumo’s Ultimaster Tansei DES (Reg)
Key Target Audience
Hospitals
Cardiology Clinics
Diagnostic Centers
Research Institutes
Medical Device Manufacturers
Healthcare Providers
Government Health Departments
Academic Institutions
Frequently Asked Questions (FAQ's)
The market was valued at USD 50 billion in 2024 and is expected to grow at a CAGR of 7.5% from 2025 to 2030.
Increasing prevalence of cardiovascular diseases and technological advancements in cardiology devices.
North America and Europe currently lead, with significant growth opportunities in Asia-Pacific
High costs, stringent regulations, and lack of skilled professionals.
Key players include Medtronic, Abbott Laboratories, and Boston Scientific Corporation.
Table of Contents
Introduction 1.1 Report Description 1.2 Research Methodology 1.2.1 Data Mining 1.2.2 Market Modeling and Forecasting 1.2.3 Data Validation 1.2.4 Industry Analysis
Market Dashboard
Market Overview 3.1 Market Definition and Scope 3.2 Market Segmentation 3.2.1 By Treatment Type 3.2.2 By End-User 3.2.3 By Distribution Channel 3.2.4 By Geography 3.3 Market Dynamics 3.3.1 Drivers 3.3.2 Restraints 3.3.3 Opportunities 3.3.4 Challenges
Global Cardiology Devices Market by Treatment Type 4.1 Introduction 4.2 Market Size and Growth Rate by Treatment Type (2024-2030) 4.2.1 Diagnostic Devices 4.2.1.1 Electrocardiographs (ECG) - 12-Lead ECG - Single-Lead ECG - Others 4.2.1.2 Imaging Systems - Echocardiography - Cardiac MRI - Nuclear Imaging - Others 4.2.1.3 Holter Monitors - Analog Holter Monitors - Digital Holter Monitors - Others 4.2.1.4 Others
Global Cardiology Devices Market by End-User 5.1 Introduction 5.2 Market Size and Growth Rate by End-User (2024-2030) 5.2.1 Hospitals and Clinics - Cardiology Departments - Specialty Clinics 5.2.2 Diagnostic Laboratories - Independent Laboratories - Hospital-Affiliated Labs 5.2.3 Research and Academic Institutes
Global Cardiology Devices Market by Distribution Channel 6.1 Introduction 6.2 Market Size and Growth Rate by Distribution Channel (2024-2030) 6.2.1 Hospital Pharmacies - Inpatient Dispensing - Specialty Drug Distribution 6.2.2 Retail Pharmacies - Chain Pharmacies - Standalone Pharmacies 6.2.3 Online Pharmacies
Global Cardiology Devices Market by Geography 7.1 Introduction 7.2 Market Size and Growth Rate by Region (2024-2030) 7.2.1 North America - United States - Canada 7.2.2 Europe - Germany - France - United Kingdom - Rest of Europe 7.2.3 Asia Pacific - China - Japan - India - Southeast Asia - Rest of Asia Pacific 7.2.4 Latin America - Brazil - Rest of Latin America 7.2.5 Middle East & Africa (MEA) - GCC - North Africa - South Africa - Rest of Middle East & Africa
Table 1: Global Cardiology Devices Market Size, by Treatment Type, 2024-2030
Table 2: Global Cardiology Devices Market Size, by End-User, 2024-2030
Table 3: Global Cardiology Devices Market Size, by Distribution Channel, 2024-2030
Table 4: Regional Market Sizes and Growth Rates, 2024-2030
Figure 1: Market Dynamics Overview
Figure 2: Cardiology Devices Market Segmentation by Region
Figure 3: Growth Rate of Therapeutic Devices, 2024-2030
Figure 4: Competitive Landscape Analysis
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done, and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Global Cardiology Devices Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Global Cardiology Devices Market for the past year and forecasts for the next six years. Global Cardiology Devices Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different Global Cardiology Devices Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for Global Cardiology Devices Market from different application industries in different regions.
